Dr. Michael Bar, MD (he/him) is a Hematologist, Oncologist in Stamford, CT with over 18 years of experience. What is your opinion of Dr. Michael Bar, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Michael Bar, MD has received over $11,964 which includes payments from the following companies:
$3,718.00 from Celgene Corporation
$2,270.50 from Pharmacyclics, Inc
$1,545.00 from GlaxoSmithKline, LLC.
$1,488.60 from Janssen Biotech, Inc.
$875.00 from GENZYME CORPORATION
$650.00 from COMSORT, Inc
$550.00 from Millennium Pharmaceuticals, Inc.
$266.45 from sanofi-aventis U.S. LLC
$150.00 from Athenex Pharmaceutical Division, LLC
$131.02 from Pfizer Inc.
$100.00 from Cardinal Health 110, LLC
$63.73 from Novartis Pharmaceuticals Corporation
$44.64 from Seattle Genetics, Inc.
$36.08 from Astellas Pharma US Inc
$34.02 from Sirtex Medical Inc
$15.29 from CSL Behring
$14.56 from Teva Pharmaceuticals USA, Inc.
$11.75 from Amgen Inc.
Payments received by Dr. Michael Bar, MD were from the following categories:
$7,906.16 Consulting Fee
$2,783.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!